(Q39362979)

11 September 2017

title

Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque (English)

1 reference

11 September 2017

0 references

1 reference

1 reference

0 references

Nanshan Zhong

1 reference

11 September 2017

Martin C Woodle

1 reference

11 September 2017

Bao-jian Li

1 reference

11 September 2017

Qingquan Tang

1 reference

11 September 2017

Du Cheng

1 reference

11 September 2017

Chuan Qin

1 reference

11 September 2017

Frank Y Xie

1 reference

11 September 2017

Qiang Wei

1 reference

11 September 2017

Jun Xu

1 reference

11 September 2017

Yijia Liu

1 reference

11 September 2017

Bo-jian Zheng

1 reference

11 September 2017

Patrick Y Lu

1 reference

11 September 2017

language of work or name

English

0 references

publication date

21 August 2005

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

944-951

1 reference

Aetiology: Koch's postulates fulfilled for SARS virus

11 September 2017

cites work

1 reference

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

21 January 2018

1 reference

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

21 January 2018

1 reference

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

21 January 2018

1 reference

The Genome sequence of the SARS-associated coronavirus

21 January 2018

1 reference

Lung pathology of fatal severe acute respiratory syndrome.

21 January 2018

1 reference

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

21 January 2018

1 reference

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

21 January 2018

1 reference

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

21 January 2018

1 reference

Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1.

21 January 2018

1 reference

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

21 January 2018

1 reference

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

21 January 2018

1 reference

Interferon-beta 1a and SARS coronavirus replication

21 January 2018

1 reference

Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

21 January 2018

1 reference

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques

21 January 2018

1 reference

Macaque model for severe acute respiratory syndrome

21 January 2018

1 reference

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

21 January 2018

1 reference

An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus

21 January 2018

1 reference

Inhibition of Virus Replication by RNA Interference

21 January 2018

1 reference

Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference

21 January 2018

1 reference

Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells

21 January 2018

1 reference

Stability of dopamine and epinephrine solutions up to 84 hours

21 January 2018

1 reference

Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure

21 January 2018

1 reference

Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice

21 January 2018

1 reference

Inhibition of respiratory viruses by nasally administered siRNA.

21 January 2018

1 reference

Protection against lethal influenza virus challenge by RNA interference in vivo.

21 January 2018

1 reference

Inhibition of influenza virus production in virus-infected mice by RNA interference

21 January 2018

1 reference

Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer

21 January 2018

1 reference

Biodistribution study of phosphonolipids: a class of non-viral vectors efficient in mice lung-directed gene transfer

21 January 2018

1 reference

Peptide nucleic acids targeted to the mouse proNPFF(A) reveal an endogenous opioid tonus

21 January 2018

1 reference

Specificity of short interfering RNA determined through gene expression signatures

21 January 2018

1 reference

Genomewide demarcation of RNA polymerase II transcription units revealed by physical fractionation of chromatin

21 January 2018

1 reference

Expression profiling reveals off-target gene regulation by RNAi

21 January 2018

1 reference

Activation of the interferon system by short-interfering RNAs

21 January 2018

1 reference

Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3.

21 January 2018

1 reference

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

21 January 2018

1 reference

The acute respiratory distress syndrome

21 January 2018

1 reference

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

21 January 2018

1 reference

An interferon-gamma-related cytokine storm in SARS patients

21 January 2018

1 reference

Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus

21 January 2018

1 reference

12 December 2020

Genomewide view of gene silencing by small interfering RNAs

1 reference

12 December 2020

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

1 reference

12 December 2020

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

1 reference

12 December 2020

Lack of interferon response in animals to naked siRNAs

1 reference

12 December 2020

Treatment of SARS with human interferons

1 reference

12 December 2020

Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM1280

1 reference

Dimensions Publication ID

11 September 2017

1034342862

0 references

1 reference